UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.10760296211039020-10760296211039020

2021

Volltextzugriff (PDF)

Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19

Pharmacotherapy, 2020-11, Vol.40 (11), p.1130-1151

2020

Volltextzugriff (PDF)

Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults

Journal of the American Geriatrics Society (JAGS), 2024-02, Vol.72 (2), p.631-633

2024

Volltextzugriff (PDF)

SUBSEQUENT CHANGES IN DOSING REQUIREMENTS TO PRODUCE THERAPEUTIC ANTICOAGULATION WITH INJECTABLE DIRECT THROMBIN INHIBITORS AFTER INSTITUTIONAL CHANGE TO THE ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENT

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A2104-A2104

Trujillo, Toby C.

2018

Volltextzugriff (PDF)

Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants

The American journal of emergency medicine, 2014-04, Vol.32 (4), p.375-382

2014

Volltextzugriff (PDF)

Emerging anticoagulants for venous thromboembolism prevention

American journal of health-system pharmacy, 2010-05, Vol.67 (10 Supplement 6), p.S17-S25

Trujillo, Toby C

2010

Volltextzugriff (PDF)

Approaches to Precision-based Anticoagulation management in the critically Ill

Pharmacotherapy, 2023-11, Vol.43 (11), p.1221-1236

2023

Volltextzugriff (PDF)

Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge

The Annals of pharmacotherapy, 2022-09, Vol.56 (9), p.981-987

2022

Volltextzugriff (PDF)

Antidotes for reversal of direct oral anticoagulants

Pharmacology & therapeutics (Oxford), 2019-12, Vol.204, p.107405, Article 107405

2019

Volltextzugriff (PDF)

Optimizing anticoagulation for patients receiving Impella support

Pharmacotherapy, 2021-11, Vol.41 (11), p.932-942

2021

Volltextzugriff (PDF)

Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events

Clinical therapeutics, 2020-10, Vol.42 (10), p.2084-2097

2020

Volltextzugriff (PDF)

Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism

Journal of thrombosis and thrombolysis, 2022-08, Vol.54 (2), p.276-286

2022

Volltextzugriff (PDF)

Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples

American journal of clinical pathology, 2014-05, Vol.141 (5), p.665-674

2014

Volltextzugriff (PDF)

Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients

Journal of thrombosis and thrombolysis, 2020-02, Vol.49 (2), p.259-267

2020

Volltextzugriff (PDF)

Rewards and Advancements for Clinical Pharmacists

Pharmacotherapy, 2010-01, Vol.30 (1), p.114-114

2010

Volltextzugriff (PDF)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy

The Annals of pharmacotherapy, 2016-06, Vol.50 (6), p.486-501

2016

Volltextzugriff (PDF)

Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19

Journal of thrombosis and thrombolysis, 2022-02, Vol.53 (2), p.446-453

2022

Volltextzugriff (PDF)

Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation

Pharmacotherapy, 2019-01, Vol.39 (1), p.94-108

2019

Volltextzugriff (PDF)

Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal

The American journal of emergency medicine, 2020-10, Vol.38 (10), p.2096-2100

2020

Volltextzugriff (PDF)

Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion

American journal of health-system pharmacy, 2010-05, Vol.67 (10 Supplement 6), p.S26-S30

2010

Volltextzugriff (PDF)

The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes

American journal of pharmaceutical education, 2016-12, Vol.80 (10), p.174-174, Article 174

2016

Volltextzugriff (PDF)

Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism

Pharmacotherapy, 2013-06, Vol.33 (6), p.650-664

2013

Volltextzugriff (PDF)

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures

Cardiology in review, 2018-09, Vol.26 (5), p.245-254

2018

Volltextzugriff (PDF)

When patients on target-specific oral anticoagulants need surgery

Cleveland Clinic journal of medicine, 2014-10, Vol.81 (10), p.629-639

2014

Volltextzugriff (PDF)

Evaluation of empiric versus nomogram‐based direct thrombin inhibitor management in patients with suspected heparin‐induced thrombocytopenia

American journal of hematology, 2011-03, Vol.86 (3), p.267-272

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(54)
Berichte
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding

Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19

Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults

SUBSEQUENT CHANGES IN DOSING REQUIREMENTS TO PRODUCE THERAPEUTIC ANTICOAGULATION WITH INJECTABLE DIRECT THROMBIN INHIBITORS AFTER INSTITUTIONAL CHANGE TO THE ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENT

Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants

Emerging anticoagulants for venous thromboembolism prevention

Approaches to Precision-based Anticoagulation management in the critically Ill

Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge

Antidotes for reversal of direct oral anticoagulants

Optimizing anticoagulation for patients receiving Impella support

Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events

Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism

Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples

Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients

Rewards and Advancements for Clinical Pharmacists

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy

Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19

Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation

Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal

Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion

The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes

Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures

When patients on target-specific oral anticoagulants need surgery

Evaluation of empiric versus nomogram‐based direct thrombin inhibitor management in patients with suspected heparin‐induced thrombocytopenia

Suchergebnisse filtern